Tianjin Chase Sun Pharmaceutical (300026.SZ) issued a profit warning, with an estimated net profit of 48-62 million yuan for the year 2024, a year-on-year decrease of 90.53%-87.76%.

Tianjin Chase Sun Pharmaceutical (300026.SZ) announced its performance forecast for 2024, with the company expecting a net profit attributable to shareholders of the listed company of 48-62 million yuan, a year-on-year decrease of 90.53%-87.76%; after deducting non-recurring gains and losses, the net profit is expected to be 20-30 million yuan, a year-on-year decrease of 94.67%-92.01%.